跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
Idarubicin hydrochloride Injection 5 mg in 5 mL (2)
Approved
STANDARD
Idarubicin hydrochloride Injection 5 mg in 5 mL (2)
Pfizer (Perth) Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
523115e2297c4926
Company
Pfizer (Perth) Pty Ltd
Type
Standard
Approval Details
Approval Id
523115e2297c4926
Product Name
Idarubicin hydrochloride Injection 5 mg in 5 mL (2)
Artg Id
317188
Artg Name
Idarubicin hydrochloride Injection 5 mg in 5 mL (2)
Sponsor
Pfizer (Perth) Pty Ltd
Company Detail Path
/organization/pfizer-perth-pty-ltd
Artg Date
2019-05-03
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
LIE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
523115e2297c4926
Type
Standard
Back to TGA Approvals
Idarubicin hydrochloride Injection 5 mg in 5 mL (2) - TGA Drug Approval Details
